These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32920322)

  • 1. COVID-19 in Parkinson's disease: Report on prevalence and outcome.
    Artusi CA; Romagnolo A; Imbalzano G; Marchet A; Zibetti M; Rizzone MG; Lopiano L
    Parkinsonism Relat Disord; 2020 Nov; 80():7-9. PubMed ID: 32920322
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of home confinement during COVID-19 pandemic on Parkinson's disease.
    Kumar N; Gupta R; Kumar H; Mehta S; Rajan R; Kumar D; Kandadai RM; Desai S; Wadia P; Basu P; Mondal B; Sanchita ; Rawat A; Meka SS; Mishal B; Prashanth LK; Srivastava AK; Goyal V
    Parkinsonism Relat Disord; 2020 Nov; 80():32-34. PubMed ID: 32937224
    [No Abstract]   [Full Text] [Related]  

  • 3. An educational case series of Parkinson's disease during the COVID-19 pandemic.
    Lo Monaco MR; Colacicco G; Marotta J; Bentivoglio AR;
    Rev Neurol (Paris); 2021; 177(1-2):134-136. PubMed ID: 32951860
    [No Abstract]   [Full Text] [Related]  

  • 4. Behind the Mask: Recognizing Facial Features of Parkinson's Disease During the COVID-19 Pandemic.
    Soares C; Carneiro DR; Dias R; Ferreira D; Sousa M; Oliveira A; Massano J; Morgadinho A; Rosas MJ; Araújo R
    Mov Disord; 2021 Jun; 36(6):1285-1286. PubMed ID: 33834516
    [No Abstract]   [Full Text] [Related]  

  • 5. E-Rehabilitation: One solution for patients with Parkinson's disease in COVID-19 era.
    Srivastav AK; Samuel AJ
    Parkinsonism Relat Disord; 2020 Jun; 75():128-129. PubMed ID: 32532625
    [No Abstract]   [Full Text] [Related]  

  • 6. Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Speeckaert MM; Speeckaert R; Delanghe JR
    Mov Disord; 2020 Sep; 35(9):1497. PubMed ID: 33400280
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of probable Parkinson's disease after SARS-CoV-2 infection.
    Cohen ME; Eichel R; Steiner-Birmanns B; Janah A; Ioshpa M; Bar-Shalom R; Paul JJ; Gaber H; Skrahina V; Bornstein NM; Yahalom G
    Lancet Neurol; 2020 Oct; 19(10):804-805. PubMed ID: 32949534
    [No Abstract]   [Full Text] [Related]  

  • 8. What can Parkinson's disease teach us about COVID-19?
    Tipton PW; Wszolek ZK
    Neurol Neurochir Pol; 2020; 54(2):204-206. PubMed ID: 32323862
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID-19) Pandemic.
    Salari M; Zali A; Ashrafi F; Etemadifar M; Sharma S; Hajizadeh N; Ashourizadeh H
    Mov Disord; 2020 Jul; 35(7):1095-1096. PubMed ID: 32395849
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid worsening in Parkinson's disease may hide COVID-19 infection.
    Hainque E; Grabli D
    Parkinsonism Relat Disord; 2020 Jun; 75():126-127. PubMed ID: 32414669
    [No Abstract]   [Full Text] [Related]  

  • 11. In reply to: Helmich and Bloem (2020) "The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities".
    Edwards E; Carroll C
    J Parkinsons Dis; 2020; 10(3):1267-1268. PubMed ID: 32597820
    [No Abstract]   [Full Text] [Related]  

  • 12. May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2?
    Spina Tensini F; Spina Tensini T; Franklin GL; Teive HAG
    Parkinsonism Relat Disord; 2020 Aug; 77():20. PubMed ID: 32575004
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to: Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Cereda E; Fasano A; Pezzoli G
    Mov Disord; 2020 Sep; 35(9):1498. PubMed ID: 33400277
    [No Abstract]   [Full Text] [Related]  

  • 14. Implementation of Telemedicine for Urgent and Ongoing Healthcare for Patients with Parkinson's Disease During the COVID-19 Pandemic: New Expectations for the Future.
    Cubo E; Hassan A; Bloem BR; Mari Z;
    J Parkinsons Dis; 2020; 10(3):911-913. PubMed ID: 32417800
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to: "Can the 2019 Novel Coronavirus Cause Parkinson's Disease?".
    Achbani A; Sine H; Naciri A; Baba MA; Kharbach A; Bouchriti Y; Nejmeddine M
    Mov Disord; 2020 Oct; 35(10):1726. PubMed ID: 33068480
    [No Abstract]   [Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 in Parkinson's Disease Patients: A Case-Control Study.
    Salari M; Etemadifar M; Zali A; Medghalchi A; Tehrani Fateh S; Aminzade Z; Bagheri Moghaddam S
    Mov Disord; 2021 Apr; 36(4):794-795. PubMed ID: 33733511
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of the Coronavirus Disease 2019 Pandemic on Motor Symptoms in Parkinson's Disease: An Observational Study.
    Kainaga M; Shirota Y; Kodama S; Toda T; Hamada M
    Mov Disord; 2021 Nov; 36(11):2461-2463. PubMed ID: 34432329
    [No Abstract]   [Full Text] [Related]  

  • 18. A Post-COVID-19 Parkinsonism in the Future?
    Boika AV
    Mov Disord; 2020 Jul; 35(7):1094. PubMed ID: 32395872
    [No Abstract]   [Full Text] [Related]  

  • 19. [Risk and course of COVID-19 in patients with Parkinson's disease].
    Zalyalova ZA; Khasanova DM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):152-156. PubMed ID: 34693704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mental Health, Physical Activity, and Quality of Life in Parkinson's Disease During COVID-19 Pandemic.
    Shalash A; Roushdy T; Essam M; Fathy M; Dawood NL; Abushady EM; Elrassas H; Helmi A; Hamid E
    Mov Disord; 2020 Jul; 35(7):1097-1099. PubMed ID: 32428342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.